CSIMarket
 


Lyra Therapeutics Inc   (LYRA)
Other Ticker:  
 

Cumulative Lyra Therapeutics Inc 's Working Capital Ratio for Trailing Twelve Months Period

LYRA's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LYRA Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 41.38 % -46.4 % -35.56 % -20.69 % -23.45 %
Y / Y Current Assets Growth -6.51 % -3.37 % 109.1 % 110.42 % 84.33 %
Working Capital Ratio for Trailing Twelve Months Period 7.63 8.68 7.95 6.2 5.02
Total Ranking # 488 # 473 # 489 # 773 # 978
Seq. Current Liabilities Growth 238.35 % -59.83 % -2.18 % 6.36 % 28.26 %
Seq. Current Assets Growth -11.27 % 39.45 % -15.9 % -10.16 % -8.29 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to doubling in Current Liabilities in the III. Quarter to $19 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 7.63 below Lyra Therapeutics Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 59 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Lyra Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about LYRA
Working Capital Ratio LYRA in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 60
Sector # 384
S&P 500 # 619


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
17.86 8.03 3.49
(Mar 31 2021)   (Mar 31 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Talkspace Inc   20.60 
Alpha Tau Medical Ltd   18.52 
Co diagnostics Inc   17.08 
Neurometrix Inc   16.74 
Utah Medical Products Inc  15.71 
Vivos Inc  15.44 
Cvrx inc  14.55 
Transmedics Group Inc   13.57 
Modular Medical Inc   13.49 
Novocure Limited  13.34 
Vicarious Surgical Inc   13.11 
Hyperfine Inc   12.76 
Sight Sciences Inc   12.39 
Heartbeam Inc   12.38 
Collplant Biotechnologies Ltd   12.29 
Inmode Ltd   12.14 
Rewalk Robotics Ltd   10.19 
Pulse Biosciences Inc   10.19 
Femasys Inc   10.16 
Akili Inc   9.92 
Abiomed Inc   9.83 
Si bone inc   9.76 
Iradimed Corporation  9.70 
Axonics Inc   9.52 
Neuropace Inc   9.43 
The Beauty Health Company  9.28 
Silk Road Medical Inc   9.08 
Rxsight Inc   9.00 
Invivo Therapeutics Holdings Corp   8.91 
Shockwave Medical Inc   8.84 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com